2.
吉非替尼与厄洛替尼患者特征比较
Characteristics comparing between gefitinib and erlotinib
Characteristics (n=54) | Gefitinib (n=26) | Erlotinib (n=28) | P |
Male/Female | 3/23 | 11/17 | 0.021 |
Smoking/non-smoking | 1/25 | 9/19 | 0.008 |
Adenocarcenoma /Non-adenocarcenoma | 26/0 | 27/1 | 0.510 |
19 del/L858R | 14/12 | 19/9 | 0.219 |